In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $47.44 in the prior trading day, Qiagen NV (NYSE: QGEN) closed at $48.38, up 1.98%. In other words, the price has increased by $1.98 from its previous closing price. On the day, 1.76 million shares were traded. QGEN stock price reached its highest trading level at $48.39 during the session, while it also had its lowest trading level at $46.755.
Ratios:
Our goal is to gain a better understanding of QGEN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.92 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.89. For the most recent quarter (mrq), Quick Ratio is recorded 2.30 and its Current Ratio is at 2.60. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.45.
On June 24, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $55.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’25 when Thierry Bernard bought 25,000 shares for $48.80 per share.
ROLAND SACKERS bought 31,423 shares of QGEN for $1,546,257 on Aug 15 ’25. On Aug 14 ’25, another insider, ROLAND SACKERS, who serves as the Officer of the company, bought 18,577 shares for $49.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QGEN now has a Market Capitalization of 9966229504 and an Enterprise Value of 10432528384. As of this moment, Qiagen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.79, and their Forward P/E ratio for the next fiscal year is 18.48. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.62. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.83 while its Price-to-Book (P/B) ratio in mrq is 2.73. Its current Enterprise Value per Revenue stands at 5.038 whereas that against EBITDA is 10.253.
Stock Price History:
The Beta on a monthly basis for QGEN is 0.68, which has changed by 0.03130436 over the last 52 weeks, in comparison to a change of 0.15507638 over the same period for the S&P500. Over the past 52 weeks, QGEN has reached a high of $51.82, while it has fallen to a 52-week low of $37.59. The 50-Day Moving Average of the stock is 5.57%, while the 200-Day Moving Average is calculated to be 5.36%.
Shares Statistics:
The stock has traded on average 1.25M shares per day over the past 3-months and 1588800 shares per day over the last 10 days, according to various share statistics. A total of 206.00M shares are outstanding, with a floating share count of 205.78M. Insiders hold about 0.49% of the company’s shares, while institutions hold 72.88% stake in the company. Shares short for QGEN as of 1765756800 were 6490875 with a Short Ratio of 4.15, compared to 1763078400 on 5856272. Therefore, it implies a Short% of Shares Outstanding of 6490875 and a Short% of Float of 4.44.
Dividends & Splits
In the trailing 12 months, QGEN’s forward annual dividend rate was 0.263, compared to 0.25 this year. Against a Trailing Annual Dividend Yield of 0.0055438452. The current Payout Ratio is 0.00% for QGEN, which recently paid a dividend on 2025-07-02 with an ex-dividend date of 2026-01-08. Stock splits for the company last occurred on 2017-01-25 when the company split stock in a 962:1000 ratio.
Earnings Estimates
Its stock is currently analyzed by 9.0 different market analysts. The consensus estimate for the next quarter is $0.61, with high estimates of $0.63 and low estimates of $0.59.
Analysts are recommending an EPS of between $2.91 and $2.36 for the fiscal current year, implying an average EPS of $2.51. EPS for the following year is $2.68, with 13.0 analysts recommending between $3.12 and $2.55.
Revenue Estimates
10 analysts predict $528.58M in revenue. The current quarter. It ranges from a high estimate of $529.61M to a low estimate of $527M. As of. The current estimate, Qiagen NV’s year-ago sales were $521.2MFor the next quarter, 10 analysts are estimating revenue of $511.15M. There is a high estimate of $517.2M for the next quarter, whereas the lowest estimate is $504.47M.
A total of 17 analysts have provided revenue estimates for QGEN’s current fiscal year. The highest revenue estimate was $2.1B, while the lowest revenue estimate was $2.04B, resulting in an average revenue estimate of $2.08B. In the same quarter a year ago, actual revenue was $1.98BBased on 17 analysts’ estimates, the company’s revenue will be $2.2B in the next fiscal year. The high estimate is $2.25B and the low estimate is $2.17B.
